ALAB
Another day, another giant insider sale
Astera Labs CEO and Director Jitendra Mohan filed to sell 412,500 shares of common stock on April 17, 2026, at about $170.78 a pop. That pencils out to roughly $70.5 million — which is not exactly a “lightening the load” type of move.
Why investors care
Insider sales are the market’s version of overhearing someone say, “I’ve got a few things in the works.” Sometimes it’s just tax planning, diversification, or an executive finally wanting to buy something fancier than office coffee.
But in this case, the optics matter because the shares include:
- 71,730 RSUs acquired on December 1, 2025
- 340,770 founder shares from November 21, 2017
That means this isn’t just a quick trim — it’s part of a longer-running exit pattern. The filing also says the combined divestiture reaches 791,688 shares, worth about $122 million.
The big picture
Astera Labs investors have to read this as a signal, not a verdict. One insider sale won’t make or break the story, but when the CEO is routinely cashing out tens of millions, the market starts asking the annoying-but-necessary question: is management still riding the same horse as shareholders?
Big picture: the business may still be humming, but the capital-markets message is getting a little louder than the product roadmap.